MarketsandMarkets

Western Blotting Market Worth $374.2 Million by 2018

Western Blotting Market report categories the Global market by Application (Disease Diagnosis/Agriculture/Biomedical Research), Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), End-User & Geography

 

Dallas, TX -- (SBWIRE) -- 11/07/2014 -- The report “Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018” analyzes and studies the major market drivers, threats, opportunities, and challenges.

Browse 63 market data tables, 24 figures spread through 201 pages and in-depth TOC on “Western Blotting Market”
http://www.marketsandmarkets.com/Market-Reports/western-blotting-market-235810711.html

Early buyers will receive 10% customization on this report.

This report studies the global Western Blotting Market over the forecast period of 2013 to 2018.This market was valued at $296.0 million in 2013 and is poised to grow at a CAGR of 4.8% from 2013 to 2018, to reach $374.2 million by 2018.

Western blotting is one of the most commonly used confirmatory tests for diagnosing diseases. This technique is extensively used in many pharmaceutical and biotechnology industries, academic research institutes, and diagnostic laboratories. This technique comprises a number of manual error-prone steps, hence companies are launching automated instruments. Thus, the instruments are increasingly being adopted by researchers as they not only simplify the work and give accurate results but also save considerable time.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=235810711

Automation in the western blotting workstations, global increase in life science R&D spending, growing proteomics market, rising prevalence of HIV, and companies focusing on validating the antibodies are the key factors that are expected to drive the growth of this market. However, high costs of primary antibodies and the emergence of alternative technologies restrain the growth of this market.

On the basis of applications, the Western Blotting Market is segmented into disease diagnosis, agriculture, biomedical and biochemical research, and others (QC test in biopharmaceutical industry and biologics).
The global western blotting market is categorized into four broad segments, namely, products, applications, end users, and geographies. On the basis of products, the market comprises instruments and consumables. Instruments are further sub-segmented by type into manual, semi-automated, and automated.

Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=235810711

On the basis of applications, the western blotting market includes diseases diagnosis, agriculture, biochemical and biomedical research, and others. In 2014, the biochemical and biomedical research accounted for the largest share of the global western blotting application market. The market by end users comprises pharmaceuticals and biotechnology companies, academic and research institutes, and diagnostic laboratories. On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia, and the Rest of the World (RoW).

Some of the major players in the global Western Blotting Market include Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.),Sigma-Aldrich Corporation (U.S.), Merck Millipore (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Roche Applied Science(U.S.), Protein Simple, Inc. (U.S.), LI-COR Biosciences (U.S.), and Advansta, Inc. (U.S.).

Browse related reports

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: mailto:sales@marketsandmarkets.com
Visit MarketsandMarkets Blog
http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn
http://www.linkedin.com/company/marketsandmarkets